unlearn.ai

About unlearn.ai

TwinRCTs by unlearn.ai introduces a groundbreaking approach to clinical research using patient-specific digital twins powered by artificial intelligence.

This innovative technology allows for more informed decision-making, faster trial enrollment, and optimized treatment observation, all without increasing participant numbers.

By generating accurate digital replicas based on extensive historical clinical data, TwinRCTs enables precise predictions of clinical outcomes at any future point, facilitating early go/no-go decisions.

It supports designing smaller, more efficient randomized controlled trials aligned with regulatory standards like EMA and FDA guidance.

The platform accelerates clinical development timelines, reduces trial costs, and enhances data insights across various disease areas including Alzheimer’s, ALS, and metabolic diseases.

Collaborations with leading biopharma companies demonstrate its real-world application, with notable results such as a 33% reduction in control arm size and four months saved in enrollment time.

TwinRCTs is transforming how clinical trials are designed, conducted, and analyzed, making therapies accessible faster and more efficiently than ever before..

Smart Features

• AI-generated patient digital twins for precise clinical outcome predictions
• Accelerated trial timelines and resource savings
• Smaller, more efficient randomized controlled trials
• Enhanced decision-making with real-time outcome forecasts
• Supports trial design optimization and regulatory compliance
• Applicable across neuroscience, immunology, metabolic diseases

Use Cases & Applications

• Accelerating drug development in Alzheimer’s and neurological disorders
• Optimizing clinical trial design and participant selection
• Reducing trial costs and duration
• Supporting interim analyses and go/no-go decisions
• Enhancing trial accuracy and success rates

Who is it for?

• Pharmaceutical companies
• Biotech firms
• Clinical research organizations
• Regulatory agencies
• Medical research institutions

Business Opportunities in unlearn.ai

Leveraging digital twin technology offers entrepreneurs and startups a unique opportunity to develop specialized AI platforms for clinical trial optimization.

By creating tailored solutions for biotech firms and research institutions, new businesses can tap into the growing demand for efficient, cost-effective drug development tools.

Offering consulting, data analysis, or custom digital twin services could open lucrative pathways in the expanding field of AI-driven healthcare innovation..